A Study to Assess the Safety and Efficacy of ASP8062 as an Add-on Therapy to Buprenorphine/Naloxone in Participants With Opioid Use Disorder
Clinical trial NCT05062577 · WITHDRAWN
Trial details
- NCT number
- NCT05062577
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-08
- Primary completion
- 2023-02-28
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.